Bone Therapeutics appoints Anne Leselbaum, MD as Chief Medical Officer Read more about Bone Therapeutics appoints Anne Leselbaum, MD as Chief Medical Officer
Bone Therapeutics provides update on the progress of clinical studies Read more about Bone Therapeutics provides update on the progress of clinical studies
Bone Therapeutics agrees final settlement with the FSMA regarding clinical studies communication issues in 2016 and 2017 Read more about Bone Therapeutics agrees final settlement with the FSMA regarding clinical studies communication issues in 2016 and 2017
Bone Therapeutics: Notice of Extraordinary Shareholders’ Meeting on 23 August 2021 Read more about Bone Therapeutics: Notice of Extraordinary Shareholders’ Meeting on 23 August 2021
Bone Therapeutics strengthens its financial structure with the implementation of its financing agreement with the European Investment Bank Read more about Bone Therapeutics strengthens its financial structure with the implementation of its financing agreement with the European Investment Bank
Bone Therapeutics announces topline results from Phase III knee osteoarthritis study with its enhanced viscosupplement JTA-004 Read more about Bone Therapeutics announces topline results from Phase III knee osteoarthritis study with its enhanced viscosupplement JTA-004
Bone Therapeutics reacts to the press release issued by Hybrigenics Read more about Bone Therapeutics reacts to the press release issued by Hybrigenics
Bone Therapeutics reports half year 2021 results Read more about Bone Therapeutics reports half year 2021 results
Bone Therapeutics appoints Lieve Creten as interim Chief Financial Officer Read more about Bone Therapeutics appoints Lieve Creten as interim Chief Financial Officer
Bone Therapeutics signs research partnership with Implant Therapeutics to access induced Pluripotent Stem Cells (iPSC) Read more about Bone Therapeutics signs research partnership with Implant Therapeutics to access induced Pluripotent Stem Cells (iPSC)
